More recently, insulin and IGF-1 have been demonstrated to induce the expression of the zinc transporter LIV-1 in ER positive breast cancer cells [62] and the regulation of this zinc transporter may be important for invasiveness and estrogen-independent cell growth [64]. This evidence concerns the gene INS and breast carcinoma.